Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Low-Dose Curcumin Nanoparticles Normalise Blood Pressure in Male Wistar Rats with Diet-Induced Metabolic Syndrome.

du Preez R, Pahl J, Arora M, Ravi Kumar MNV, Brown L, Panchal SK.

Nutrients. 2019 Jul 8;11(7). pii: E1542. doi: 10.3390/nu11071542.

2.

Oral Drug Delivery Technologies-A Decade of Developments.

Kaur G, Arora M, Ravi Kumar MNV.

J Pharmacol Exp Ther. 2019 Sep;370(3):529-543. doi: 10.1124/jpet.118.255828. Epub 2019 Apr 22. Review.

PMID:
31010845
3.

Urolithin A Mitigates Cisplatin-Induced Nephrotoxicity by Inhibiting Renal Inflammation and Apoptosis in an Experimental Rat Model.

Guada M, Ganugula R, Vadhanam M, Ravi Kumar MNV.

J Pharmacol Exp Ther. 2017 Oct;363(1):58-65. doi: 10.1124/jpet.117.242420. Epub 2017 Aug 7.

PMID:
28784820
4.

Towards scale-up and regulatory shelf-stability testing of curcumin encapsulated polyester nanoparticles.

Grama CN, Venkatpurwar VP, Lamprou DA, Ravi Kumar MN.

Drug Deliv Transl Res. 2013 Jun;3(3):286-93. doi: 10.1007/s13346-013-0150-2.

PMID:
25788136
5.

Featuring the special issue editors Dr. M.N.V. Ravi Kumar, Dr. Manicka V. Vadhanam and Dr. Jamal M. Arif.

Ravi Kumar MN, Vadhanam MV, Arif JM.

Cancer Lett. 2013 Jun 28;334(1):1-2. doi: 10.1016/j.canlet.2013.03.013. Epub 2013 Mar 22. No abstract available.

PMID:
23523872
6.

Nanotheraputics.

Ravi Kumar MN, Blanco-Prieto MJ, Waterhouse DN.

Cancer Lett. 2013 Jul 1;334(2):155-6. doi: 10.1016/j.canlet.2013.02.047. Epub 2013 Mar 21. No abstract available.

PMID:
23523611
7.

Novel Validated Stability-Indicating UPLC Method for the Estimation of Naproxen and its Impurities in Bulk Drugs and Pharmaceutical Dosage Form.

Venkatarao P, Nagendra Kumar M, Ravi Kumar M.

Sci Pharm. 2012 Oct-Dec;80(4):965-76. doi: 10.3797/scipharm.1207-12. Epub 2012 Sep 9.

8.

The efficacy of aerosol treatment with non-ionic surfactant vesicles containing amphotericin B in rodent models of leishmaniasis and pulmonary aspergillosis infection.

Alsaadi M, Italia JL, Mullen AB, Ravi Kumar MN, Candlish AA, Williams RA, Shaw CD, Al Gawhari F, Coombs GH, Wiese M, Thomson AH, Puig-Sellart M, Wallace J, Sharp A, Wheeler L, Warn P, Carter KC.

J Control Release. 2012 Jun 28;160(3):685-91. doi: 10.1016/j.jconrel.2012.04.004. Epub 2012 Apr 10.

PMID:
22516093
9.

Can efficient delivery systems leverage benefits of antioxidants leading to potential medicines?

Ravi Kumar MN.

Drug Discov Today. 2012 May;17(9-10):407-8. doi: 10.1016/j.drudis.2012.01.024. Epub 2012 Feb 4. No abstract available.

PMID:
22326671
10.

Antacid co-encapsulated polyester nanoparticles for peroral delivery of insulin: development, pharmacokinetics, biodistribution and pharmacodynamics.

Sharma G, van der Walle CF, Ravi Kumar MN.

Int J Pharm. 2013 Jan 2;440(1):99-110. doi: 10.1016/j.ijpharm.2011.12.038. Epub 2011 Dec 30.

PMID:
22227604
11.

Tissue localization of nanoparticles is altered due to hypoxia resulting in poor efficacy of curcumin nanoparticles in pulmonary hypertension.

Devadasu VR, Wadsworth RM, Ravi Kumar MN.

Eur J Pharm Biopharm. 2012 Apr;80(3):578-84. doi: 10.1016/j.ejpb.2011.12.008. Epub 2011 Dec 30.

PMID:
22227367
12.
13.

Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats.

Sharma G, Wilson K, van der Walle CF, Sattar N, Petrie JR, Ravi Kumar MN.

Eur J Pharm Biopharm. 2010 Oct;76(2):159-69. doi: 10.1016/j.ejpb.2010.07.002. Epub 2010 Jul 22.

PMID:
20655382
14.

Evaluating the potential of polymer nanoparticles for oral delivery of paclitaxel in drug-resistant cancer.

Bhardwaj V, Plumb JA, Cassidy J, Ravi Kumar MN.

Cancer Nanotechnol. 2010;1(1-6):29-34. Epub 2010 Sep 7.

15.

Isolation of high molecular weight DNA from marine sponge bacteria for BAC library construction.

Ouyang Y, Dai S, Xie L, Ravi Kumar MS, Sun W, Sun H, Tang D, Li X.

Mar Biotechnol (NY). 2010 Jun;12(3):318-25. doi: 10.1007/s10126-009-9223-0. Epub 2009 Aug 15.

PMID:
19685098
16.

Current approaches to stabilising and analysing proteins during microencapsulation in PLGA.

van der Walle CF, Sharma G, Ravi Kumar M.

Expert Opin Drug Deliv. 2009 Feb;6(2):177-86. doi: 10.1517/17425240802680169 . Review.

PMID:
19239389
17.

Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone.

Italia JL, Yahya MM, Singh D, Ravi Kumar MN.

Pharm Res. 2009 Jun;26(6):1324-31. doi: 10.1007/s11095-009-9841-2. Epub 2009 Feb 13.

PMID:
19214716
18.

High-performance liquid chromatographic analysis of amphotericin B in rat plasma using alpha-naphthol as an internal standard.

Italia JL, Singh D, Ravi Kumar MN.

Anal Chim Acta. 2009 Feb 16;634(1):110-4. doi: 10.1016/j.aca.2008.12.006. Epub 2008 Dec 7.

PMID:
19154818
19.

Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats.

Kalaria DR, Sharma G, Beniwal V, Ravi Kumar MN.

Pharm Res. 2009 Mar;26(3):492-501. doi: 10.1007/s11095-008-9763-4. Epub 2008 Nov 8.

PMID:
18998202
20.

Adsorption and oxidation of aromatic amines by metal hexacyanoferrates(II).

Alam T, Tarannum H, Ravi Kumar MN, Kamaluddin.

Talanta. 2000 May 5;51(6):1097-105.

PMID:
18967941
21.

Pharmacodynamic evaluation of oral estradiol nanoparticles in estrogen deficient (ovariectomized) high-fat diet induced hyperlipidemic rat model.

Mittal G, Chandraiah G, Ramarao P, Ravi Kumar MN.

Pharm Res. 2009 Jan;26(1):218-23. doi: 10.1007/s11095-008-9725-x. Epub 2008 Sep 12.

PMID:
18787933
22.

Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.

Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MN.

J Control Release. 2007 May 14;119(1):77-85. Epub 2007 Feb 3.

PMID:
17349712
24.

Design and evaluation of biodegradable, biosensitive in situ gelling system for pulsatile delivery of insulin.

Kashyap N, Viswanad B, Sharma G, Bhardwaj V, Ramarao P, Ravi Kumar MN.

Biomaterials. 2007 Apr;28(11):2051-60. Epub 2007 Jan 19.

PMID:
17240443
25.

Liposomes as targeted drug delivery systems in the treatment of breast cancer.

Sharma G, Anabousi S, Ehrhardt C, Ravi Kumar MN.

J Drug Target. 2006 Jun;14(5):301-10. Review.

PMID:
16882550
26.

A water-soluble fluorescent fluoride ion probe based on Alizarin Red S-Al(III) complex.

Sai Sathish R, Ravi Kumar M, Nageswara Rao G, Anil Kumar K, Janardhana C.

Spectrochim Acta A Mol Biomol Spectrosc. 2007 Feb;66(2):457-61. Epub 2006 Apr 3.

PMID:
16859979
27.

Characterisation of a series of acetals/ketals of bis(2-nitrophenyl) ethanediol and bis(4,5-dimethoxy-2-nitrophenyl) ethanediol under APCI mass spectrometric conditions.

Bhaskar G, Prabhakar S, Ravi Kumar M, Narsimhaji ChV, Srinivas K, Vairamani M.

J Mass Spectrom. 2006 Dec;41(12):1608-14.

PMID:
16830358
28.

Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration.

Bala I, Bhardwaj V, Hariharan S, Kharade SV, Roy N, Ravi Kumar MN.

J Drug Target. 2006 Jan;14(1):27-34.

PMID:
16603449
29.

Estimation of trace elements in some anti-diabetic medicinal plants using PIXE technique.

Naga Raju GJ, Sarita P, Ramana Murty GA, Ravi Kumar M, Reddy BS, Charles MJ, Lakshminarayana S, Reddy TS, Reddy SB, Vijayan V.

Appl Radiat Isot. 2006 Aug;64(8):893-900. Epub 2006 Mar 31.

PMID:
16580220
30.

Preparation and characterization of chitosan and trimethyl-chitosan-modified poly-(epsilon-caprolactone) nanoparticles as DNA carriers.

Haas J, Ravi Kumar MN, Borchard G, Bakowsky U, Lehr CM.

AAPS PharmSciTech. 2005 Aug 10;6(1):E22-30.

31.
32.

Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy.

Hariharan S, Bhardwaj V, Bala I, Sitterberg J, Bakowsky U, Ravi Kumar MN.

Pharm Res. 2006 Jan;23(1):184-95. Epub 2006 Nov 8.

PMID:
16267632
33.

Formation of benzylic-DNA adducts resulting from 7,12-dimethylbenz[a]anthracene in vivo.

Ravi Kumar MN, Vadhanam MV, Horn J, Flesher JW, Gupta RC.

Chem Res Toxicol. 2005 Apr;18(4):686-91.

PMID:
15833028
34.

Cationic silica nanoparticles as gene carriers: synthesis, characterization and transfection efficiency in vitro and in vivo.

Ravi Kumar MN, Sameti M, Mohapatra SS, Kong X, Lockey RF, Bakowsky U, Lindenblatt G, Schmidt H, Lehr CM.

J Nanosci Nanotechnol. 2004 Sep;4(7):876-81.

PMID:
15570975
35.
36.

Nanoparticle-mediated gene delivery: state of the art.

Ravi Kumar M, Hellermann G, Lockey RF, Mohapatra SS.

Expert Opin Biol Ther. 2004 Aug;4(8):1213-24. Review.

PMID:
15268657
37.

Preparation and characterization of cationic PLGA nanospheres as DNA carriers.

Ravi Kumar MN, Bakowsky U, Lehr CM.

Biomaterials. 2004 May;25(10):1771-7.

PMID:
14738840
38.

In vitro and in vivo investigations on the photodynamic activity of core-modified expanded porphyrin--ammonium salt of 5,10,15,20-tetrakis-(meso-p-sulfonato phenyl)-25,27,29-trithia sapphyrin.

Parmeswaran D, Pushpan SK, Srinivasan A, Ravi Kumar M, Chandrashekar TK, Ganesan S.

Photochem Photobiol. 2003 Nov;78(5):487-95.

PMID:
14653581
39.

Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene delivery.

Sameti M, Bohr G, Ravi Kumar MN, Kneuer C, Bakowsky U, Nacken M, Schmidt H, Lehr CM.

Int J Pharm. 2003 Nov 6;266(1-2):51-60.

PMID:
14559393
40.

Nano and microparticles as controlled drug delivery devices.

Ravi Kumar MN.

J Pharm Pharm Sci. 2000 May-Aug;3(2):234-58. Review.

41.

Drug release behavior of beads and microgranules of chitosan.

Gupta KC, Ravi Kumar MN.

Biomaterials. 2000 Jun;21(11):1115-9.

PMID:
10817263

Supplemental Content

Loading ...
Support Center